CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Exogenus is developing Exo-Wound, a new treatment for chronic wounds using factors from Umbilical Cord Blood cells to enhance healing. The project seeks to clinically validate this innovative therapy, which shows promise in improving wound healing outcomes compared to existing treatments.
Currently, there are about 50 million reported cases globally of patients suffering from hard-to-close wounds, which constitute a severe cost burden to the global healthcare systems.
Considering that for these patients up to 70% of the wounds may not heal with standard care, there is a high demand for new solutions with better efficacy for the treatment of wounds.
Cell therapies have emerged as promising therapeutic strategies to solve the problem of chronic wounds, but the limited engraftment a…
EXOGENUS THERAPEUTICS SA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
